Ketchum hires Con Franklin as London healthcare MDCon Franklin has joined communications consultancy Ketchum as its managing director of healthcare in London. He joins the Share XKetchum hires Con Franklin as London healthcare MDhttps://pharmaphorum.com/news/ketchum-con-franklin-healthcare-md/
Cello Health acquires Firstlight PR’s health teamCello Health has boosted its comms offering with the acquisition of Firstlight Public Relations’ ten-strong healthcare business. The Share XCello Health acquires Firstlight PR’s health teamhttps://pharmaphorum.com/news/cello-health-acquires-firstlight-pr-health/
DMD campaigners: Advocating for changeThe internet and social media are often heralded as a panacea for rare disease patients and their carers Share XDMD campaigners: Advocating for changehttps://pharmaphorum.com/disease-spotlight/dmd-main/dmd-campaigners-advocating-change/
10/12/2018Digital therapeutics and healthcare innovationOverview Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics Share XDigital therapeutics and healthcare innovationhttps://pharmaphorum.com/debates-insight-digital/digital-therapeutics-and-healthcare-innovation/
Parenting as a DMD patientParenting as a DMD patient The sleepless nights and steep learning curve that will be familiar to any Share XParenting as a DMD patienthttps://pharmaphorum.com/views-analysis-digital/parenting-as-a-dmd-patient/
The NHS and integrated care systems – how can pharma play its part?The concept of joining up health and social care has been around a long time – but now Share XThe NHS and integrated care systems – how can pharma play its part?https://pharmaphorum.com/views-analysis-market-access/nhs-integrated-care-systems/
The changing face of pharmaceutical launchesThe industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues Share XThe changing face of pharmaceutical launcheshttps://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/
FDA approves Janssen’s HIV combination SymtuzaJanssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient Share XFDA approves Janssen’s HIV combination Symtuzahttps://pharmaphorum.com/news/fda-janssen-hiv-symtuza/
Otsuka has high hopes for its ‘drug creation engine’ acquisitionOtsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug Share XOtsuka has high hopes for its ‘drug creation engine’ acquisitionhttps://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/
